These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5564320)

  • 21. Phenazone (antipyrine) metabolism and distribution in young and elderly adults.
    Liddell DE; Williams FM; Briant RH
    Clin Exp Pharmacol Physiol; 1975; 2(6):481-7. PubMed ID: 1236602
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic control of drug levels in man: antipyrine.
    Vesell ES; Page JG
    Science; 1968 Jul; 161(3836):72-3. PubMed ID: 5690279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of phenylbutazone and tolbutamide in man.
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oral contraceptives on plasma clearance.
    Carter DE; Bressler R; Hughes MR; Haussler MR; Christian D; Heine MW
    Clin Pharmacol Ther; 1975 Dec; 18(6):700-7. PubMed ID: 173489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of 14C-antipyrine in suspensions of isolated rat liver cells.
    Aarbakke J; Bessesen A; Morland J
    Acta Pharmacol Toxicol (Copenh); 1977 Sep; 41(3):225-34. PubMed ID: 578651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine.
    Sultatos LG; Dvorchik BH; Vesell ES; Shand DG; Branch RA
    Clin Pharmacokinet; 1980; 5(3):263-73. PubMed ID: 7389235
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys.
    Hucker HB; Stauffer SC; White SE
    J Pharm Sci; 1972 Sep; 61(9):1490-2. PubMed ID: 4115915
    [No Abstract]   [Full Text] [Related]  

  • 28. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enflurane anesthesia and antipyrine metabolism.
    Duvaldestin P; Mauge F; Desmonts JM
    Clin Pharmacol Ther; 1981 Jan; 29(1):61-4. PubMed ID: 7460476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics in the elderly.
    Triggs EJ; Nation RL; Long A; Ashley JJ
    Eur J Clin Pharmacol; 1975; 8(1):55-62. PubMed ID: 1233203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug metabolism in malnourished children: a study with antipyrine.
    Homeida M; Karrar ZA; Roberts CJ
    Arch Dis Child; 1979 Apr; 54(4):299-302. PubMed ID: 110271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs and genes.
    Motulsky AG
    Ann Intern Med; 1969 Jun; 70(6):1269-72. PubMed ID: 4182785
    [No Abstract]   [Full Text] [Related]  

  • 33. Factors affecting antipyrine metabolism in West African villagers.
    Fraser HS; Bulpitt CJ; Kahn C; Mould G; Mucklow JC; Dollery CT
    Clin Pharmacol Ther; 1976 Sep; 20(3):369-76. PubMed ID: 954356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
    Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytochrome P-450 and drug oxidation.
    Davies DS
    Biochem J; 1969 Dec; 115(5):23P-24P. PubMed ID: 4391248
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antipyrine metabolism in lung cancer patients].
    Radzikowska E; Gaździk W; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1993; 61(9-10):496-502. PubMed ID: 8111326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary antipyrine half-life: a useful measure of hepatic drug metabolism.
    Brooks PM; Bell MA; Burns H
    Br J Clin Pharmacol; 1976 Oct; 3(5):945-6. PubMed ID: 973995
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of long-term phenothiazine treatment on drug metabolism.
    Kolakowska T; Franklin M; Alapin B
    Br J Clin Pharmacol; 1975 Feb; 2(1):25-8. PubMed ID: 1234485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of fever on antipyrine metabolism in children.
    Forsyth JS; Moreland TA; Rylance GW
    Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.